Wisniewski K E, Gordon-Majszak W, Maslinski S, Heaney-Kieras J
New York State Office of Mental Retardation and Developmental Disabilities, Department of Pathological Neurobiology, Staten Island 10314.
Am J Med Genet. 1992 Feb 15;42(4):568-74. doi: 10.1002/ajmg.1320420429.
The neuronal ceroid lipofuscinoses (NCL) are a group of inherited neurodegenerative diseases characterized by massive intralysosomal accumulation of storage materials. We have studied the protein patterns in 5 NCL, 5 control, and one Alzheimer disease brains. When protein patterns in NCL and control brain gray matter homogenates were examined by SDS-PAGE, NCL brains showed an absence or greatly reduced amounts of the Mr 160-180 kDa component and reduced amounts of the Mr 29-36 kDa component. Concomitantly, an increase in several components with Mrs of 45-50 kDa was noted. The 180 kDa polypeptide appears to be a glycoprotein because it was bound to the lectins concanavalin A and Ulex europaeus. Recently, the abnormal processing of amyloid protein precursor (APP) and its potential role in NCL have been suggested. Possible defects in tissue proteases and protease inhibitors may be considered responsible for the presence of these amyloid beta protein precursor fragments. To examine this possibility we are using polyclonal antibodies to the C terminal 672-695 (APP) and monoclonal antibodies to inter-alpha-trypsin inhibitor. Polypeptides with molecular weights of approximately 35-38 kDa were detected in the NCL brain, but not in controls in both cases. These findings suggest abnormal protein processing in NCL brain tissue, disturbances in protein and glycoconjugate metabolism, impaired lysosomal function (i.e., metabolic enzyme and/or proteases/proteinase inhibitor abnormalities), and the involvement of improperly processed APP.
神经元蜡样脂褐质沉积症(NCL)是一组遗传性神经退行性疾病,其特征是溶酶体内大量储存物质积累。我们研究了5例NCL患者、5例对照者以及1例阿尔茨海默病患者大脑中的蛋白质模式。当通过SDS-PAGE检测NCL和对照者脑灰质匀浆中的蛋白质模式时,NCL患者的大脑显示出Mr 160 - 180 kDa成分缺失或含量大幅降低,以及Mr 29 - 36 kDa成分含量降低。同时,注意到几种Mr为45 - 50 kDa的成分有所增加。180 kDa多肽似乎是一种糖蛋白,因为它与伴刀豆球蛋白A和欧洲荆豆凝集素结合。最近,有人提出淀粉样蛋白前体(APP)的异常加工及其在NCL中的潜在作用。组织蛋白酶和蛋白酶抑制剂的可能缺陷可能被认为是这些淀粉样β蛋白前体片段存在的原因。为了研究这种可能性,我们正在使用针对C末端672 - 695(APP)的多克隆抗体和针对α-胰蛋白酶抑制剂的单克隆抗体。在NCL患者的大脑中检测到分子量约为35 - 38 kDa的多肽,但在两种情况下的对照者大脑中均未检测到。这些发现表明NCL脑组织中存在异常的蛋白质加工、蛋白质和糖缀合物代谢紊乱、溶酶体功能受损(即代谢酶和/或蛋白酶/蛋白酶抑制剂异常)以及加工不当的APP的参与。